CURRENT PUBLICATIONS

Mislabeled Units of Umbilical Cord Blood Detected by a Quality Assurance Program at the Transplantation Center
In a 6-year period, 2 of 871 (0.2%) cord blood units sent for transplantation were mislabeled and potentially would have been transplanted incorrectly. This error rate of 1 per 249 (0.4%) patients could have potentially devastating consequences. [Blood]

Impact of HLA Disparity in the Graft-Versus-Host Direction on Engraftment in Adult Patients Receiving Reduced-Intensity Cord Blood Transplantation
Result indicates the significant role of HLA disparity in the GVH direction in the successful engraftment. [Blood]

Immune Reconstitution after Cord Blood Transplants Supported by Coinfusion of Mobilized Hematopoietic Stem Cells from a Third Party Donor
Results suggest that thymic function contributes substantially to the recovery of T-cell populations in adults receiving dual CB/TPD-MHSC transplants. [Bone Marrow Transplant]

Hematopoietic Cell Transplantation for Children with Acute Lymphoblastic Leukemia in Second Complete Remission: Similar Outcomes in Recipients of Unrelated Marrow and Umbilical Cord Blood versus Marrow from HLA Matched Sibling Donors
Results support the continued investigation of URD HCT for ALL in CR2, and suggest the timing of HCT in these children should be based primarily on the risk of relapse with conventional chemotherapy and not on the type of donor available. [Bone Marrow Transplant]

POLICY NEWS

Conflict of Interest Disclosures in Clinical Trials Need to be Clearer
When enrolling patients in a clinical trial, researchers should disclose relevant financial relationships that might affect a patient's decision about participation, such as owning stock in the company that funds the study, or having a patent on the device being tested.

Research Trove: Patients' Online Data
As the trend to use online private data contributed by patients in medical research progresses in the country, experts are divided over the benefits and ethical implications of such a data model.

FOOD AND DRUG ADMINISTRATION (United States)

Food and Drug Administration Transparency Task Force; Meeting - Reopening of Comment Period, 41711-41712 [E9-19778]

Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Financial Disclosure by Clinical Investigators

Revision of the Requirements for Publication of License Revocation; Confirmation of Effective Date, 42175 [E9-20119]

Post Marketing Safety Reports for Human Drug and Biological Products: Electronic Submission Requirements, 42184-42203 [E9-19682]

Events

2nd TERMIS World Congress In Conjunction With 2009 Seoul Stem Cell Symposium
August 31-September 3, 2009
Seoul, South Korea

XXXVI Annual Meeting of the European Society for Artificial Organs 2009   
September 2-5, 2009
Compiègne, France

16th International Society of Developmental Biologists Congress
September 6-10, 2009
Edinburgh, United Kingdom

International Society for Hematology and Stem Cells 38th Annual Scientific Meeting
September 9-12, 2009
Athens, Greece

51st ASH Annual Meeting and Exposition
December 9-12, 2009
New Orleans, LA

2010 BMT Tandem Meetings
February 24-28, 2010
Orlando, Florida

The European Group for Blood & Marrow Transplantation Annual Meeting
March 21-24, 2010
Vienna, Austria

Canadian Blood and Marrow Transplant Consortium Annual Meeting
April 7-10, 2010
Vancouver, BC

16th Annual International Society for Cellular Therapy Meeting
May 22-26, 2010
Philadelphia, Pennsylvania

Visit our events page to stay up to date with the latest events in the cell, gene and immunotherapy community.

Have we missed an important article or publication in Cord Blood News? Click here to submit!